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Defects in iron absorption and utilization lead to iron deficiency and anemia. While iron transport by transferrin receptor-mediated endocytosis
is well understood, it is not completely clear how iron is transported from the endosome to the mitochondria where heme is synthesized. We
undertook a positional cloning project to identify the causative mutation for the hemoglobin-deficit (hbd) mouse mutant, which suffers from a
microcytic, hypochromic anemia apparently due to defective iron transport in the endocytosis cycle. As shown by previous studies, reticulocyte
iron accumulation in homozygous hbd/hbd mice is deficient despite normal binding of transferrin to its receptor and normal transferrin uptake in
the cell. We have identified a strong candidate gene for hbd, Sec15l1, a homologue to yeast SEC15, which encodes a key protein in vesicle
docking. The hbd mice have an exon deletion in Sec15l1, which is the first known mutation of a SEC gene homologue in mammals.
D 2005 Elsevier Inc. All rights reserved.Keywords: Iron metabolism; Mouse mutant; AnemiaIron is fundamental to the biology of living organisms and,
until recently, iron transport remained poorly understood [1,2].
Critical genes responsible for iron homeostasis have been
identified by positional cloning with the microcytic anemia
(mk) and the sex-linked anemia (sla) mutant mice [3,4], in
addition to the study of iron metabolism defects in human and
zebrafish [5–9]. However, other genes playing essential roles
in iron homeostasis have yet to be discovered. This includes the
genes responsible for transferring iron from the endosome to
the mitochondria for the production of heme.
Diferric transferrin binds to the transferrin receptor (TfR) on
the cell membrane, and the transferrin–TfR complex is
internalized into clathrin-coated vesicles by endocytosis [10].
The vesicles lose their clathrin coat and fuse with endosomes, in
which acidification occurs, and iron is released from transferrin.
DMT1 (divalent metal transporter-1) protein facilitates the
passage of iron through the endosomal membrane into the0888-7543/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: rwhite@cmh.edu (R.A. White).cytoplasm [3]. Recently, an essential transporter for iron
importation into the mitochondria was discovered and is
disrupted in zebrafish frascati mutants with profound hypo-
chromic anemia. The frascati gene product is a novel member of
a mitochondrial solute transporter family that transports
metabolites across the inner mitochondrial membrane [11].
However, it is still unclear how iron is transported from the
endosome to the mitochondria. It has been proposed that the
highly efficient transfer of iron from endosome to mitochondria
in normal reticulocytes may result from the endosome navigat-
ing the cell to dock onto themitochondria to transfer iron directly
to the latter (the so-called ‘‘kiss and run’’ hypothesis) [12].
The hemoglobin-deficit mouse mutant (gene symbol hbd)
exhibits a severe, microcytic anemia, which is not due to iron
deficiency since serum iron levels are above normal [13].
Hemoglobin levels are reduced in hbd mice and zinc
protoporphyrin levels are increased, indicating a deficiency in
heme synthesis. Previous studies have shown that the hbd
mouse has a defect in iron utilization, presumably in the release
of iron from the endosome in reticulocytes [12–14]. Although
transferrin uptake was normal in reticulocytes from hbd/hbd
and +/+ mice, iron acquisition was significantly reduced in5) 668 – 673
www.el
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to the transferrin receptor in the hbd reticulocytes and enters
the cells by the endosomal pathway. However, iron does not
accumulate in the cells. Therefore, a defect occurs in iron
acquisition distal to the binding of transferrin to its receptor. A
comparable mutant has been reported in a Chinese hamster
ovary cell line that has a defect in transferrin-receptor-mediated
endocytosis [15]. Binding and internalization of transferrin
proceed normally in this hamster cell line but iron does not
accumulate in the cell, similar to the case for hbd reticulocytes.
The phenotype of hbd mice can be transferred by bone marrow
transplantation to irradiated mice, showing that the defect is
intrinsic to the bone marrow [16]. Conversely, hbd mice can be
cured by transplantation of normal bone marrow [17] but are
not cured by intraperitoneal iron–dextran injections. Collec-
tively, these data suggest that iron utilization in the bone
marrow is the primary defect.
The hbd mouse arose as a spontaneous mutation and is
inherited in an autosomal recessive manner [13]. The hbd
gene has been mapped to mouse chromosome 19, but the
gene has not been previously identified [18]. We set out to
positionally clone the hbd mutant gene and now report the
identification of a strong candidate gene for hbd, Sec15l1, a
homologue to the yeast gene encoding vesicle docking
protein, SEC15 [19–23].
Results
Hematology of hbd mice
Blood samples were obtained from adult C57BL/6J hbd/
hbd, +/hbd, and +/+ mice. Table 1 illustrates marked
disturbances of red blood cell parameters in hbd/hbd mice.
Homozygous hbd/hbd mice showed a significant reduction ( p <
0.05) in hematocrit and hemoglobin values. The mean cell
volume (MCV) shows that the anemia in hbd mice is a
microcytic anemia. Also, there was a significant elevation in Zn
protoporphyrin levels in hbd mice, suggesting ineffective
utilization of iron and deficient hemoglobin production.
High-resolution mapping of the hbd locus
A low-resolution backcross study was previously used to
locate hbd on chromosome 19 in mouse [18]. We set out to
positionally clone the hbd gene using a high-resolution map
from the mating of B6MOLDF1 +/hbd with C57BL/6J hbd/Table 1





MCV (fl) Hb (g/dl) Zn protoporphyrin
(Ag/dl)
+/+ 8.8 T 0.3 50 T 1 57.0 T 2.2 14.6 T 0.1 40 T 2
+/hbd 8.6 T 0.5 52 T 1 60.9 T 3.0 14.2 T 0.2 43 T 3
hbd/hbd 9.1 T 0.4 45 T 1a 49.3 T 2.1a 10.8 T 0.4a 290 T 15a
Data are means T standard error of the mean.
a Mean value for hbd/hbd is significantly different from either +/+ or +/hbd
mice by t test at p < 0.05.hbd mice to generate 2454 backcross mice. The MOLD/Rk
strain is highly polymorphic and allowed the identification of
the greatest number of genetic markers for the mapping of the
hbd locus. The backcross mice were scored by measuring the
level of Zn protoporphyrin, which is elevated in hbd anemic
mice, from peripheral blood samples. Using eight dinucleotide
CA-repeat microsatellite genetic markers, we were able to
define a critical region for the hbd gene. Of 2454 backcross
mice we found no recombinant types for one marker
(D19Mit101) (Fig. 1). The critical region (in which the hbd
gene must be located) was defined by the flanking markers
Kif11, at 0.24 cM on the proximal side (with six crossover
backcross mice), and Fer1l3, at 0.04 cM on the distal side
(with one crossover backcross mouse) (Fig. 1). The calculated
size of the hbd critical region, which includes all of these
genetic markers, is 836 kb as determined by the sequence
available in GenBank contig NT 039689. It was estimated that
Fer1l3 was only 80 kb from the hbd locus based on the average
length of genomic DNA per centimorgan (2000 kb/cM) across
the mouse genome. GenBank contig NT 039689 contains three
functional genes in this region: Hhex (hematopoietically
expressed homeobox), Sec15l1 (secretion protein 15-like 1),
and Cyp26a1 (cytochrome P450, family 26, subfamily a1).
Haplotype data for the backcrosses are shown in Fig. 1.
Mutation analysis of the hbd gene
Our approach for mutation analysis was to amplify exons
for each gene in the hbd critical region by genomic PCR using
primers derived from flanking sequence. The results were
examined for gene deletions, insertions, or large rearrange-
ments as determined by the size of the PCR product generated
from normal and mutant DNA. The only gene in the hbd
critical region with a defect was the Sec15l1 gene, which was
shown to have a deletion of exon 8 in hbd genomic DNA (Fig.
2a). All other functional genes in the critical region were
amplified and sequenced for control C57BL/6J and hbd mice.
None showed large deletions, insertions, or rearrangements and
there were no sequence mutations except for a silent
polymorphism in exon 2 of the Hhex gene, which also was
present in multiple mouse strains (SWR/J, AKR/J, CAST/Rk,
A/J, Balbc/J, and WB/Re). Sec15l1 exons in C57BL/6J and
hbd mice were also sequenced to confirm similarity to the
Sec15l1 GenBank sequence. Several backcross progeny were
randomly selected to verify the deletion of exon 8 in Sec15l1 in
hbd mice by genomic PCR (Fig. 2b). In addition, exon 8 of
Sec15l1 was amplified from the genomic DNA of 12 mouse
strains (A/J, AKR/J, Balb/cJ, C57BL/10J, CAST/Rk, CFO,
C3H/He, DBA/2J, MOLD/Rk, SWR/J, WB/Re, and 129sv/J)
to show that the absence of exon 8 in hbd mice was not a
polymorphic form of the gene (data not shown).
The Sec15l1 exon 8 deletion in hbd mice was verified by
long-range genomic PCR. Using primers derived from exon 7
and exon 9, long-range genomic PCR of hbd and wild-type
DNA revealed a 4.6-kb downward shift from 7.6 to 3.0 kb,
consistent with the Sec15l1 gene deletion (Fig. 3a). Genomic
PCR, followed by DNA sequencing, was also used to
Fig. 2. Mutation analysis of the Sec15l1 gene in hbd mice. (a) Genomic PCR o
exons 1 through 22 of the Sec15l1 gene in control C57BL/6J +/+ and C57BL
6J hbd/hbd DNA shows deletion of exon 8 in the hbd mouse (indicated by
asterisk). Molecular weight marker (M) is a 100 bp ladder. (b) Randomly
selected backcross mouse DNAs (+/hbd normal, N, and hbd/hbd) were
amplified for exon 8 of the Sec15l1 gene. Concordance of the deletion with the
hbd phenotype is perfect.
Fig. 1. High-resolution genetic map of the hbd critical region on mouse
chromosome 19. Relative distances in centimorgans (cM) are shown. The
segregation pattern for the phenotype and genetic markers is indicated on the
right. The black squares represent the +/hbd heterozygous genotypes, while the
white squares represent the homozygous hbd/hbd phenotypes. The numbers of
mice with the haplotypes are indicated below. The asterisks refer to the animals
used to define the critical region for the hbd locus with six recombinants for the
Kif11 locus and one recombinant for Fer1l3. CA repeat polymorphisms for the
backcross were found for the following genes starting at the nucleotide number
listed: Kif11 nt 1328, Fer1l3 nt 40,858, Rbp4 nt 5332, and Cpeb3 nt 148,241.
Genetic markers can be found at www.informatics.jax.org and in GenBank,
Accession No. NT 039689.
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A 1.0-kb genomic PCR amplicon, which spanned the Sec15l1
deletion, was generated by using primers within intron 7 and
intron 8. The hbd deletion extends from nt 28,707 in intron 7 to
nt 33,247 in intron 8 of Sec15l1 (GenBank contig NT 039689).
The deleted DNA sequence in hbd mice is replaced by 38 bp of
DNA starting at nt 28,707 of the Sec15l1 gene and likely
represents remnants of the recombination event that led to the
deletion. The Sec15l1 genomic deletion in hbd mice is
illustrated in Fig. 3b.
The Sec15l1 gene deletion was confirmed in hbd genomic
DNA by an independent approach. A Southern blot of BamHI-
digested hbd and C57BL/6J DNA was probed with a 226-bp
Sec15l1 cDNA of exons 7 through 9 (Fig. 4). Genomic bands
of 5.4 and 2.4 kb were absent in the hbd lanes confirming a
deletion. A de novo 3.3-kb band was present in hbd genomic
DNA and is likely derived from the 5.4-kb band. All three
bands (5.4, 3.3, and 2.4 kb) were present in heterozygous +/
hbd genomic DNA.
Expression analysis of the hbd mutation
Expression of the Sec15l1 gene in normal +/+, hbd, and
heterozygous +/hbd mice was examined by RT-PCR using
primers whose products extend from Sec15l1 exon 7 to exon 9.
Consistent with an exon 8 deletion, the RT-PCR product from
hbd/hbd mice showed a smaller Sec15l1 transcript (157 bp)
than the amplicon from normal reticulocyte RNA (226 bp)
(Fig. 5a). The +/hbd RT-PCR sample showed both bands (226
and 157 bp) as expected for heterozygosity of the deletion
mutation. As a result of the exon 8 deletion, Sec15l1
expression was predicted to result in an in-frame transcriptspliced from exon 7 to exon 9. To verify the in-frame deletion,
the 157-bp Sec15l1 amplicon from the hbd reticulocyte RT-
PCR was isolated and sequenced (Fig. 5b). The resulting
nucleotide sequence confirms that exon 7 is spliced onto exon
9 and the coding sequence is in-frame. Exon 8 of the Sec15l1
gene is 69 bp in length and codes for exactly 23 amino acids.
Consequently, a truncated SEC15L1 protein (90 kDa) is
predicted to be produced in hbd mice compared to full-length
SEC15L1 protein in normal mice (93 kDa). Among the amino
acids deleted in the hbd SEC15L1 protein, there are 2 amino
acids important for tertiary structure: a cysteine residue at
position 283 and a proline residue at position 287.
Normal expression of Sec15l1 was examined in wild-type
mice by RT-PCR using a forward primer for exon 7 and reverse
primer for exon 9. Sec15l1 RNA was detected in multiple
tissues, including reticulocyte, spleen, bone marrow, kidney,
brain, liver (Fig. 5c), and duodenum (Fig. 5d). Therefore,
Sec15l1 RNA is expressed in nonhematopoietic tissues
(kidney, brain, and duodenum) in addition to hematopoietic
tissues (reticulocyte, spleen, bone marrow, and liver).
Discussion
The products of at least 14 genes, including SEC15, are
involved specifically in vesicular transport from the Golgi
apparatus in the yeast Saccharomyces cerevisiae [22]. The
exocyst complex is specifically located at the site of vesicle
fusion [19]. The mouse SEC15L1 protein is similar to SEC15
of yeast, but its specific function has not been determined.
Sec15l1 may be involved in vesicle docking like its yeast
homolog. The peptide homology of mouse SEC15L1 to yeast
SEC15 is 19%, whereas the peptide homology between human
and mouse SEC15L1 is 92%. There are at least 26 SEC-like
genes found in the mouse genome (www.informatics.jax.org),
and this is the first known mutation of a SEC-like gene in
mammals.
The key to understanding the defect in hbd mice presumably
lies in its involvement in the endocytic pathway in which
endosomes are formed, iron is released, and the endosomes aref
/
Fig. 3. Genomic PCR analysis of Sec15l1 mutation in hbd mice. (a) Genomic PCR from C57BL/6J +/+ and hbd/hbd mouse DNA using a forward primer within
exon 7 and a reverse primer within exon 9 shows a shift in product by 4.6 kb, which represents the deletion of the Sec15l1 gene in hbd mice. (b) Schematic depiction
of the partial genomic deletion of Sec15l1 in hbd animals. In C57BL/6J DNA, exons 7, 8, and 9 are present in a 7.6-kb genomic PCR product. In DNA from hbd
mice, exon 8 is deleted and the remaining fragment is 3.0 kb by genomic PCR. A 38-bp insertion located at the start of the hbd deletion and 0.6 kb from exon 7 was
detected by DNA sequencing of an hbd Sec15l1 genomic PCR product.
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gene encoding a vesicle docking protein, appears to be an
excellent candidate gene for hbd based on the finding that the
endocytosis cycle seems to be affected in hbd reticulocytes
[14]. A mutation in the Sec15l1 gene is consistent with the hbd
mutant phenotype since TfR-mediated endocytosis involves
vesicle docking.
There are two possibilities for the effect of the Sec15l1
mutation on iron metabolism in hbd reticulocytes. First, the
absence of normal SEC15L1 protein in hbd reticulocytes may
have an effect on iron transport by not allowing the docking of
the iron-containing vesicles to the endosome. Iron-containing
vesicles would likely accumulate in hbd reticulocytes under
these conditions and, in this case, iron would be expected to
increase in the mutant cells. However, previous studies have
shown that iron accumulation is lower than normal in hbd
reticulocytes [14] and therefore, this type of docking defect may
not be the primary defect. An alternative hypothesis is that
SEC15L1 may be a key protein in iron targeting to the
mitochondria. A previous proposal suggests that there is aFig. 4. Southern blot analysis of Sec15l1 deletion. C57BL/6J hbd/hbd DNA,
along with controls (B6, +/hbd), was digested with BamHI and probed with a
226-bp Sec15l1 cDNA extending from exon 7 to 9. Autoradiogram shows the
absence of bands (5.4 and 2.4 kb) in hbd, confirming the hbd deletion. A de
novo band (3.3 kb) is likely derived from the 5.4-kb band seen in normal mice.
The +/hbd lane contains all bands. HindIII-cut E size marker in kilobases is
indicated.
Fig. 5. Sec15l1 mRNA expression in hbd and normal mice. Molecular weight
marker (M) is a 100 bp ladder. (a) RT-PCR of Sec15l1 exon 7 to 9 from
reticulocytes of hbd/hbd, C57BL/6J normal (+/+) control, and +/hbd mice
shows absence of the 226-bp normal product in hbd preparations and presence
of a smaller 157-bp deletion, which corresponds to a deletion of exon 8.
Heterozygous +/hbd mice have both the normal and the truncated Sec15l1
bands. (b) Sequence analysis of the hbd Sec15l1 RT-PCR product reveals the
presence of exons 7 and 9 with the complete absence of exon 8. The hbd
Sec15l1 mRNA results in the codon sequence being in-frame as shown below
the sequence. A smaller hbd protein is predicted to be encoded by the hbd
mutant. The 69-bp deletion in hbd RNA is in-frame and codes for a Sec15l1
protein with 23 fewer amino acids. (c) Normal expression of Sec15l1 was
examined by RT-PCR using the exon 7 forward primer and the exon 9 reverse
primer and is seen in reticulocyte (R), spleen (S), bone marrow (BM), kidney
(K), brain (Br), liver (Lv), and (d) duodenum (Du). Negative controls (no RNA)
for RT-PCR assays showed no product (data not shown).
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once there, the endosomes dock onto the mitochondria to release
iron directly to the organelle [12]. Furthermore, iron is
transported out of the endosome by DMT1 to protein(s) on the
mitochondrial membrane. The Sec15l1 mutation in hbd mice
may interfere with the docking of endosomes to mitochondria. In
the case of hbd reticulocytes, iron may not be transferred
efficiently from the endosome to the mitochondria because
vesicle docking is impaired. Absent or abnormal SEC15L1
protein in hbd mice may prevent the transient association of the
endosome with mitochondria and, therefore, not allow the
transport of iron from one organelle to the other. The hbd
endosomemay cycle back to the cell surface without transferring
iron to mitochondria and instead release iron outside the cell.
The hbd mutant suffers a hypochromic, microcytic anemia
but has no other phenotypic defects. This suggests that
SEC15L1 must have a specific function since no tissues other
than erythroid cells appear to be affected. The apparent lack of
compensation by any of the other 26 mouse SEC-like genes to
overcome the mutant phenotype in the hbd mouse also
suggests that other SEC-like gene products have their own
specific function independent of SEC15L1. In addition, it is not
surprising that the Sec15l1 mutation appears to affect only iron
transport in hbd mice since there is evidence that mutations in
one endocytic pathway do not affect other endocytic pathways.
For example, a familial hypercholesterolemia mutation in the
LDL receptor-mediated endocytosis pathway does not affect
the transferrin-mediated iron transport pathway [24]. Therefore,
Sec15l1 is likely to play a specific role in one pathway alone.
Sec15l1 RNA is expressed in hematopoietic tissues as
determined by RT-PCR (which is expected for a protein with a
role in iron utilization for the production of heme). However,
Sec15l1 RNA is also detected in nonhematopoietic tissues.
This is not surprising since even the major iron transporter
DMT1 is expressed in many diverse nonhematopoietic tissues
in addition to hematopoietic tissues. The deletion of exon 8 in
the Sec15l1 gene of hbd mice results in the flanking exons 7
and 9 being in-frame after splicing of Sec15l1 mRNA. The
predicted outcome of the mutation is the production of a
truncated protein (90 kDa) in hbd mice in contrast to the full-
length SEC15L1 protein (93 kDa). The 23 deleted amino acids
in the SEC15L1 protein of hbd mice include a cysteine and a
proline, both of which are important to tertiary structure. There
are multiple potential disulfide bridges made possible by
several cysteine residues in the SEC15L1 protein and a
deletion of one of these amino acids is likely to disrupt the
normal tertiary structure of the protein. Therefore, the
conformation of the mutant hbd SEC15L1 protein may be
significantly changed and susceptible to proteolytic digestion.
Immunological methods will be needed to verify whether the
90-kDa Sec15l1 truncated protein product is present in hbd
reticulocytes or whether it is degraded. Ascertainment of the
function of SEC15L1 can be established from protein–protein
interaction studies, localization by immunocytochemistry, and
the use of small inhibitory RNAs in murine erythroleukemia
cells to determine the effect on iron absorption. Further analysis
of normal SEC15L1 function will uncover its direct role in ironmetabolism and whether it is involved in the mechanics of the
final, crucial step of endosomal iron transport to mitochondria.
Materials and methods
Mice
C57BL/6J hbd/hbd mice were obtained from The Jackson Laboratory (Bar
Harbor, ME, USA). The hbd mutants were identified by determining the levels
of zinc protoporphyrin in peripheral blood. Mice with a value of zinc
protoporphyrin >100 Ag/dl were scored as anemic [18]. Peripheral blood
samples were obtained from hbd/hbd and normal littermates. Zinc protopor-
phyrin was measured using a hematofluorometer Model 206D (AVIV
Biomedical, Inc., Lakewood, NJ, USA). This instrument measures zinc
protoporphyrin’s fluorescence and displays results in Ag/dl.
Hematology studies
Peripheral blood samples were obtained in hematocrit tubes from adult
C57BL/6J hbd/hbd, +/hbd, and +/+ mice. Red blood cells were counted with a
Coulter counter (Model Z1; Miami, FL, USA). Hematocrit percentage was
assessed using an Adams hematocrit reader (Becton–Dickinson, Parsippany,
NJ, USA). The MCV was calculated from these values. Hemoglobin
concentration of the red blood cells lysed in Drabkin’s solution (Stanbio
Laboratory, Boerne, TX, USA) was measured in a Perkin–Elmer Lambda 40
spectrophotometer (Norwalk, CT, USA) at a wavelength of 540 nm. Zinc
protoporphyrin was measured using a hematofluorometer Model 206D (AVIV
Biomedical, Inc.).
Genetic mapping
To generate a high-resolution map for the chromosomal region of the hbd
mutation, C57BL/6J hbd/hbd mice were mated to the highly polymorphic
MOLD/Rk strain. The (B6  MOLD)F1 +/hbd progeny were backcrossed to
the parental C57BL/6J hbd/hbd mice, which generated 2454 backcross
offspring. The +/hbd normal and hbd/hbd anemic mice were scored, and
high-molecular-weight DNAwas extracted from spleens using the Super Quick
Gene DNA extraction kit (Analytical Genetic Testing Center, Denver, CO,
USA). These DNA samples were genotyped with primer pairs (Invitrogen,
Carlsbad, CA, USA) as previously described [25] for a series of simple
sequence length polymorphisms. Genotyping was also performed for four
novel polymorphic CA repeats identified from four genes (Cpeb3, cytoplasmic
polyadenylation element binding protein; Kif11, kinesin family member 11;
Fer1l3, fer-1-like 3, also known as myoferlin; and Rbp4, retinol binding
protein 4, plasma) from a contig sequence (GenBank Accession No. NT
039689) of the hbd genomic region. The results of the mapping studies were
analyzed using the Map Manager (v2.5) computer program (K. Manly, Roswell
Park Institute, Buffalo, NY, USA) to determine the relative chromosomal
position of the hbd locus.
Mutation analysis
Genomic PCR was performed using primers derived from flanking
sequences 50 bp upstream and downstream of the exons in each gene from
the hbd critical region. The primers were chosen using the Primer 3 program
(frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) from the sequence of a
contig (GenBank Accession No. NT039689) that includes the hbd critical
region. Oligonucleotide primers were prepared by Oligos Etc. (Wilsonville,
OR, USA). Cycle conditions for genomic PCR were 1 min at 94-C, 1 min at
67-C, 1 min at 72-C for 35 cycles using the Fail Safe PCR kit (Epicentre
Technologies, Madison, WI, USA). Analytical gels were 3% GenePure 3:1
agarose (ISCB, Kaysville, UT, USA) using conditions specified by the
manufacturer’s protocol for the Fail Safe PCR Kit. A 100 bp ladder (New
England Biological Laboratories, Beverly, MA, USA) was used as a molecular
weight marker. Genomic PCR for generating the large +/+ and hbd amplicons
(7.6 and 3 kb) was performed using High Fidelity Platinum Taq DNA
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1% GenePure 3:1 agarose (ISCB) gel with a 1 kb ladder molecular weight
marker (Invitrogen). PCR products were isolated using Micro Spin S-200 HR
columns (Amersham Biosciences, Piscataway, NJ, USA) or CENTRI-SEP Spin
Columns (Princeton Separations, Inc., Adelphia, NJ, USA) prior to sequencing.
Amplicons were sequenced by the KU Medical Center Biotechnology Support
Facility (Kansas City, KS, USA) using an ABI 377 automated sequencer
(Applied Biosystems, Foster City, CA, USA). Comparison of exon sequence
was performed using the ClustalW multiple sequence alignment program
(www.ebi.ac.uk/clustalw). Sequence data analysis was performed using the
MacVector sequence analysis software (GCG, Madison, WI, USA). Primers
were generated from the intron sequence flanking each Sec15l1 exon to prevent
inadvertent amplification of other Sec15 family members. A Sec15l1 226-bp
cDNA probe was used for Southern blot analysis with techniques previously
described [26]. The Sec15l1 cDNA probe was produced by PCR amplification
of exons 7 to 9 from QUICK-Clone mouse kidney cDNA (BD Biosciences
Clontech, Palo Alto, CA, USA). The probe was purified using Micro Spin S-
200 HR columns (Amersham Biosciences).
RT-PCR analysis
RNA extractions from reticulocytes, spleen, bone marrow cells, kidney,
brain, and liver were performed using the RNeasy Midi Kit (Qiagen, Valencia,
CA) according to the manufacturer’s protocol. RNA extracted from mouse
duodenum was obtained from Zyagen Laboratories (San Diego, CA, USA). RT-
PCR was completed using QuantiTect SYBR Green RT-PCR kit according to
the manufacturer’s protocol. Analytical gels were the same as those described
above for genomic PCR. Normal reticulocytes were obtained from phenylhy-
drazine-treated mice prepared as previously described [27]. This drug lyses red
blood cells and induces reticulocytosis.
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